Developing coronavirus vaccines presents challenges due to rapid viral mutation rates
the verdict
SUPPORTED
the evidence backs this
confidence 79/100
Developing coronavirus vaccines presents significant ongoing challenges due to rapid viral mutation rates and immune evasion mechanisms.
Evidence for · 5
SARS‐CoV‐2 Variants and Immune Evasion: Mapping the Future of Vaccine Design
2026 · cited by 3
Reviews the evolutionary trajectory of SARS-CoV-2 and highlights rapid antigenic drift, emerging subvariants, and immune evasion as central challenges for long-term vaccine design.
See more details
More for · 4
Polymorphism and selection pressure of SARS-CoV-2 vaccine and diagnostic antigens: implications for immune evasion and serologic diagnostic performance
2020 · cited by 2
Examines antigen diversity and diversifying selection across thousands of viral genomes, noting that new clades constantly emerge and complicate broad vaccine efficacy.
Computational fingerprinting of immune-mediated pressure on SARS-CoV-2 viral evolution reveals preliminary evidence for immune-evasion
2022 · cited by 1
Uses computational modeling to demonstrate how specific viral mutations contribute to immune escape and challenge adaptive immune responses following vaccination.
Emerging SARS-CoV-2 Variants and Their Impact on Immune Evasion and Vaccine-Induced Immunity
2023 · cited by 0
Summarizes how structural mutations in the spike and RBD domains reduce neutralizing antibody responses, thereby lowering vaccine efficacy and complicating immunization efforts.
Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity
2023 · cited by 0
Analyzes how viral evolution driven by immune evasion and changing receptor-binding affinities continuously alters the antigenic profile of SARS-CoV-2.